W
WAVEMAN · COMPANY
VNRX · Volitionrx Ltd
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

VNRX

VOLITIONRX LTD
PHARMA & BIOTECH · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · CIK 0000093314
ACTIVIST 13D☆ WATCH
INSIDER NET · 180D
-
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
6
13F, latest reported quarter
REVENUE GROWTH
+40.0%
XBRL, annual
NET MARGIN
-1352.2%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
no Form 4 purchases or sales on file
CONGRESS
no member of Congress has reported trading it
FUNDS
6 funds added or opened last quarter
below 92% of Pharma & Biotech
REVENUE
+40.0% year over year
more than 76% of Pharma & Biotech
MARGIN
-1352.2% net margin
below 91% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Lagoda Investment Management, L.P. disclosed a 5%+ stake (7.4%) in the last six months.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -97.3%
-97.3%12M
-97%-64%-30%+3%2025-092025-102025-122026-032026-052026-072026-09 2025-10-14 · Reynolds Cameron John bought $56.1K2025-10-14 · Innes Guy Archibald bought $49.0K2025-10-14 · STILL TIMOTHY I bought $24.5K2025-09-12 · Reynolds Cameron John bought $9.9K2025-11-17 · Reynolds Cameron John bought $7.0K2026-09-04 · Lagoda Investment Management, L.P. filed a 5%+ stake (7.4%)2026-09-04 · Lagoda Investment Management, LLC filed a 5%+ stake (7.4%)2026-09-04 · Fatima Dickey filed a 5%+ stake (7.4%)
INSIDER BUY13D/G STAKE
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
An activist crossed the 5% line with declared intent.
The record shows 6 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for VOLITIONRX LTD in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Reynolds Cameron John
President and CEO
BUY
2025-11-17
20,000.0
$7.0K
Reynolds Cameron John
President and CEO
BUY
2025-10-14
110,000.0
$56.1K
Innes Guy Archibald
Director
BUY
2025-10-14
96,153.0
$49.0K
STILL TIMOTHY I
Director
BUY
2025-10-14
48,076.0
$24.5K
Reynolds Cameron John
President and CEO
BUY
2025-09-12
15,000.0
$9.9K
61 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 56 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Lagoda Investment Management, L.P.
1,455,950.0 sh
$2.0M
LUMINUS MANAGEMENT LLC
156,897.0 sh
$211.8K
GEODE CAPITAL MANAGEMENT, LLC
55,537.0 sh
$75.0K
VANGUARD CAPITAL MANAGEMENT LLC
50,684.0 sh
$68.4K
Wealthspire Advisors, LLC
45,000.0 sh
$60.8K
5%+ owners
13D = intent to influence · 13G = passive
Lagoda Investment Management, L.P.
ACTIVIST 13D · 2026-09-04
7.4%
Lagoda Investment Management, LLC
ACTIVIST 13D · 2026-09-04
7.4%
Fatima Dickey
ACTIVIST 13D · 2026-09-04
7.4%
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Fidelity Extended Market Index Fund
$115.6K POSITION · AS OF 2026-02-28
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$204.8K POSITION · AS OF 2026-03-31
0.0%
Fidelity Series Total Market Index Fund
$24.6K POSITION · AS OF 2026-02-28
0.0%
Fidelity Total Market Index Fund
$30.0K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$1.7M$1.2M$775.3K$306.4K
OPERATING INCOME$-21.7M$-27.0M$-36.0M$-31.8M
NET INCOME$-23.4M$-27.0M$-35.7M$-30.6M
EPS (DILUTED)-0.31-0.50
OPERATING CASH FLOW$-19.7M$-25.9M$-18.1M$-15.3M
CASH$1.1M$3.3M$20.7M$10.9M
LONG-TERM DEBT$5.8M$4.0M$3.6M$2.8M
BUYBACKS$0$31.8K$0
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →